Table 1 Clinical and pathological characteristics of patients
Characteristic | Value |
|---|---|
Age (years; median [range]) | 47 (29 to 79) |
Histology (n [%]) | Â |
   Ductal | 33 (82%) |
   Lobular | 7 (18%) |
Tumour grade (n [%]) | Â |
   G1 | 3 (7%) |
   G2 | 21 (53%) |
   G3 | 16 (40%) |
Primary tumor (n [%]) | Â |
   T2 | 7 (17%) |
   T3 | 20 (50%) |
   T4 | 13 (33%) |
Lymph node status (n [%]) | Â |
   Positive | 24 (60%) |
   Negative | 16 (40%) |
Primary tumor (n [%]) | Â |
   IIA | 4 (10%) |
   IIB | 8 (20%) |
   IIIA | 15 (33%) |
   IIIB | 18 (38%) |
Estrogen receptor status (n [%]) | Â |
   Positive | 24 (60%) |
   Negative | 16 (40% |
Progesterone receptor status (n [%]) | Â |
   Positive | 22 (55%) |
   Negative | 18 (45%) |
Her2 receptor status (n [%]) | Â |
   Positive | 9 (23%) |
   Negative | 31 (77%) |